首页> Clinical otolaryngology and allied sciences> Molecular markers in dysplasia of the larynx: expression of cyclin-dependent kinase inhibitors p21, p27 and p53 tumour suppressor gene in predicting cancer risk.

Molecular markers in dysplasia of the larynx: expression of cyclin-dependent kinase inhibitors p21, p27 and p53 tumour suppressor gene in predicting cancer risk.

导出原文传递

翻译打印收藏纠错

第一作者： Jeannon JP

作者： Jeannon JP ^[1] ; Soames JV ; Aston V ; Stafford FW ; Wilson JA

作者单位： Department of Otolaryngology Head and Neck Surgery, University of Newcastle-upon-Tyne, Tyne and Wear, UK. ^[1]

关键词 Dysplasia NOS p27 Enzyme Inhibitor oncoprotein p21 Larynx cancer risk 喉

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical otolaryngology and allied sciences

2004年29卷6期

698-704页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Clinical otolaryngology and allied sciences

2004年29卷6期

698-704页

检索历史清除

Molecular markers in dysplasia of the larynx: expression of cyclin-dependent kinase inhibitors p21, p27 and p53 tumour suppressor gene in predicting cancer risk.

Clinical otolaryngology and allied sciences

相似文献

同项目论文

Clinical otolaryngology and allied sciences

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Molecular markers in dysplasia of the larynx: expression of cyclin-dependent kinase inhibitors p21, p27 and p53 tumour suppressor gene in predicting cancer risk.

Clinical otolaryngology and allied sciences

相似文献

同项目论文

Clinical otolaryngology and allied sciences

相关期刊

检索历史清除